Compare VRME & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRME | EVGN |
|---|---|---|
| Founded | 1999 | 1999 |
| Country | United States | Israel |
| Employees | 30 | N/A |
| Industry | EDP Services | Agricultural Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 9.6M |
| IPO Year | N/A | 2013 |
| Metric | VRME | EVGN |
|---|---|---|
| Price | $0.85 | $0.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.50 | ★ $3.50 |
| AVG Volume (30 Days) | ★ 71.2K | 58.4K |
| Earning Date | 05-12-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.85 | N/A |
| Revenue Next Year | N/A | $73.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.59 | $0.72 |
| 52 Week High | $1.51 | $2.42 |
| Indicator | VRME | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 44.23 |
| Support Level | $0.79 | $0.72 |
| Resistance Level | $0.93 | $0.87 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 38.05 | 35.95 |
VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.